REFERENCES
- Steiner al, goodman ad, powers sr. Study of a kindred with
pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and
gushing’s disease: multiple endocrine neoplasia, type 2. Medicine.
1968 Sep 1;47(5):371-409.
- Melvin KEW, Tashjian Jr AH, Miller HH 1972 Studies in familial
(medullary) thyroid carcinoma. Recent Prog Horm Res 28:399 – 470
- Gagel RF, Tashjian Jr AH, Cummings T, Papathanasopoulos N, Kaplan MM,
DeLellis RA, Wolfe HJ, Reichlin S. The clinical outcome of prospective
screening for multiple endocrine neoplasia type 2a. New England
Journal of Medicine. 1988 Feb 25;318(8):478-84.
- Schuffenecker I, Virally-Monod M, Brohet R, Goldgar D, Conte-Devolx B,
Leclerc L, Chabre O, Boneu A, Caron J, Houdent C, Modigliani E. Risk
and penetrance of primary hyperparathyroidism in multiple endocrine
neoplasia type 2A families with mutations at codon 634 of the RET
proto-oncogene. The Journal of Clinical Endocrinology & Metabolism.
1998 Feb 1;83(2):487-91.
- Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, Van
Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ. The relationship
between specific RET proto-oncogene mutations and disease phenotype in
multiple endocrine neoplasia type 2: International RET Mutation
Consortium analysis. Jama. 1996 Nov 20;276(19):1575-9.
- Ponder BAJ 2001 Multiple endocrine neoplasia type 2. In: Scriver CR
Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of
inherited disease, 8th Ed. New York: McGraw-Hill; 931–942
- Ghosh A, Nundy S, Mallick TK. How India is dealing with COVID-19
pandemic. Sensors International. 2020 Jan 1;1:100021.
- Gild M, Clifton-Bligh R, Robinson BG. Multiple Endocrine Neoplasia
Type 2 and Bone. InGenetics of Bone Biology and Skeletal Disease 2013
Jan 1 (pp. 505-513). Academic Press.
- Mannelli M, Bemporad D. Diagnosis and management of pheochromocytoma
during pregnancy. Journal of endocrinological investigation. 2002
Jun;25(6):567-71.
- Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman
WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP. 2017 Guidelines of
the American Thyroid Association for the diagnosis and management of
thyroid disease during pregnancy and the postpartum. Thyroid. 2017 Mar
1;27(3):315-89.
- Wells Jr SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N,
Machens A, Moley JF, Pacini F, Raue F. Revised American Thyroid
Association guidelines for the management of medullary thyroid
carcinoma: the American Thyroid Association Guidelines Task Force on
medullary thyroid carcinoma. Thyroid. 2015 Jun 1;25(6):567-610.
- Silva OL, Titus-Dillon P, Becker KL, Snider RH, Moore CF. Increased
serum calcitonin in pregnancy. Journal of the National Medical
Association. 1981 Jul;73(7):649.
- Tewari KS, Steiger RM, Lam ML, Rutgers JK, Berkson RA, DiSaia PJ.
Bilateral pheochromocytoma in pregnancy heralding multiple endocrine
neoplasia syndrome IIA. A case report. The Journal of reproductive
medicine. 2001 Apr 1;46(4):385-8.
- Sarathi V, Bandgar TR, Menon PS, Shah NS. Pheochromocytoma and
medullary thyroid carcinoma in a pregnant multiple endocrine
neoplasia-2A patient. Gynecological Endocrinology. 2011 Aug
1;27(8):533-5.
- Donatini G, Kraimps JL, Caillard C, Mirallié E, Pierre F, De Calan L,
Hamy A, Larin O, Tovkay O, Cherenko S. Pheochromocytoma diagnosed
during pregnancy: lessons learned from a series of ten patients.
Surgical endoscopy. 2018 Sep;32(9):3890-900.
Table S1: Investigations for pheochromocytoma, MTC and
hyperparathyroidism as part of MEN 2A syndrome